Credit Agricole S A Cuts Stock Holdings in Axon Enterprise, Inc $AXON

Key Points

• Credit Agricole S A has reduced its stake in Axon Enterprise, Inc by 10.6%, selling 3,395 shares and leaving it with a total of 28,648 shares valued at approximately $15.07 million.
• Axon Enterprise reported a strong quarterly performance, posting $2.12 earnings per share (EPS), significantly exceeding analyst expectations and showing a revenue increase of 32.6% year-over-year.
• Insider sales included significant transactions by President Joshua Isner, who sold 15,919 shares for over $11.8 million, indicating increased activity among company executives.

Credit Agricole S A lowered its position in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 10.6% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 28,648 shares of the biotechnology company's stock after selling 3,395 shares during the quarter. Credit Agricole S A's holdings in Axon Enterprise were worth $15,067,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Fourth Dimension Wealth LLC purchased a new position in Axon Enterprise in the fourth quarter worth $30,000. TCTC Holdings LLC grew its position in Axon Enterprise by 75.0% in the first quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company's stock worth $29,000 after acquiring an additional 24 shares in the last quarter. Bartlett & CO. Wealth Management LLC grew its position in Axon Enterprise by 132.0% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock worth $31,000 after acquiring an additional 33 shares in the last quarter. Catalyst Capital Advisors LLC purchased a new position in Axon Enterprise in the first quarter worth $32,000. Finally, Alpine Bank Wealth Management purchased a new position in Axon Enterprise in the first quarter worth $40,000. Institutional investors own 79.08% of the company's stock.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, President Joshua Isner sold 15,919 shares of the firm's stock in a transaction that occurred on Friday, August 15th. The shares were sold at an average price of $746.26, for a total transaction of $11,879,712.94. Following the completion of the transaction, the president owned 238,379 shares of the company's stock, valued at approximately $177,892,712.54. This trade represents a 6.26% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Jeffrey C. Kunins sold 7,891 shares of the firm's stock in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of $750.10, for a total transaction of $5,919,039.10. Following the transaction, the insider directly owned 144,538 shares of the company's stock, valued at $108,417,953.80. This represents a 5.18% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 43,790 shares of company stock valued at $33,654,451. 4.40% of the stock is currently owned by company insiders.

Axon Enterprise Trading Down 0.0%

AXON stock traded down $0.04 during trading on Monday, reaching $766.20. The company had a trading volume of 193,857 shares, compared to its average volume of 702,915. Axon Enterprise, Inc has a 52 week low of $346.71 and a 52 week high of $885.91. The company has a market cap of $60.15 billion, a P/E ratio of 189.19, a PEG ratio of 28.12 and a beta of 1.36. The business has a 50 day moving average of $773.05 and a 200 day moving average of $673.98. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.95 and a quick ratio of 2.71.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.54 by $0.58. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The company had revenue of $668.54 million during the quarter, compared to the consensus estimate of $641.77 million. During the same period in the prior year, the firm earned $1.20 earnings per share. Axon Enterprise's revenue was up 32.6% on a year-over-year basis. Axon Enterprise has set its FY 2025 guidance at EPS. As a group, sell-side analysts forecast that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the stock. UBS Group reiterated a "neutral" rating and issued a $840.00 target price (up from $820.00) on shares of Axon Enterprise in a research report on Tuesday, August 5th. Raymond James Financial restated an "outperform" rating and set a $855.00 price target (up from $645.00) on shares of Axon Enterprise in a research report on Tuesday, August 5th. Wolfe Research assumed coverage on shares of Axon Enterprise in a research report on Monday, July 7th. They set an "outperform" rating for the company. The Goldman Sachs Group upped their price objective on shares of Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a research note on Wednesday, May 14th. Finally, Needham & Company LLC set a $870.00 price objective on shares of Axon Enterprise and gave the company a "buy" rating in a research note on Tuesday, August 5th. Thirteen analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, Axon Enterprise has an average rating of "Moderate Buy" and a consensus target price of $837.69.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.